Documentation of a safe and effective treatment for chronic itchy eyes

Effectiveness of tacrolimus eye ointment for the management of chronic vernal keratoconjunctivitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202206480800979

Enrollment

Registered

2022-06-28

Start date

2022-07-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Tacrolimus ointment

Standard treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all new and previously untreated cases diagnosed as VKC of varying severity

Exclusion criteria

Exclusion criteria: history of contact lens usage coexisting ocular infections past history of ocular surgery history of herpetic eye disease history of systemic immunosuppressive drug use

Design outcomes

Primary

Measure	Time frame
Improvement of manifestations of VKC clinically and by AS OCT	—

Secondary

Measure	Time frame
Relief of vernal keratoconjunctivitis	—

Countries

Egypt

Contacts

Public ContactFaten Helmy

Mrs

Dr.fatfota84@yahoo.com+201280320575

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026